Foreign Ownership of Celltrion Rises on Strong Earnings, IR Activities
Quick Look
- Celltrion Inc., a South Korean biotech firm, saw its foreign ownership increase to 24.5% by end-June, driven by robust earnings and expanded investor relations activities abroad.
- The company reported record-high Q2 operating profit and sales estimates.
AI-generated summary
Celltrion Inc., a South Korean biotech firm, saw its foreign ownership increase to 24.5% by end-June, driven by robust earnings and expanded investor relations activities abroad. The company reported record-high Q2 operating profit and sales estimates.






